Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) EBT Margin (2019 - 2026)

Updated

Nurix Therapeutics' EBT Margin was -993.10% in fiscal Q2 2026 (quarter ended May 31, 2026), down 896.17 percentage points from -96.93% a year earlier but up 401.24 percentage points from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) EBT Margin (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nurix Therapeutics' EBT Margin was -929.18% through May 31, 2026, down 695.57 percentage points year-over-year; for FY2025 (ended Nov 30, 2025), it came in at -314.00%, up 40.36 percentage points from FY2024.

  • EBT Margin shows a five-year change of +43.90 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, EBT Margin was -354.36% in FY2024 (-167.38 pp), -186.98% in FY2023 (+279.95 pp), -466.93% in FY2022 (-73.44 pp) and -393.49% in FY2021 (-35.59 pp).
  • Quarterly EBT Margin has moved between -1394.34% (fiscal Q1 2026) and -79.14% (fiscal Q2 2023) over five years.
  • Compared with a year earlier, EBT Margin has declined for four straight quarters, with an average year-over-year change of -370.48 percentage points over the last eight quarters.
  • The best year-over-year quarter for EBT Margin over five years was fiscal Q4 2023 (a gain of 411.96 percentage points); the worst was fiscal Q1 2026 (a drop of 1088.96 percentage points).
  • Per Business Quant data, NRIX's EBT Margin in the three fiscal quarters before Q2 2026 was -1394.34% (Q1 2026), -576.13% (Q4 2025) and -1094.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - -993.10%
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -993.10%
Feb 28, 2026 -1,394.34%
Nov 30, 2025 -576.13%
Aug 31, 2025 -1,094.77%
May 31, 2025 -96.93%
Feb 28, 2025 -305.38%
Nov 30, 2024 -440.69%
Aug 31, 2024 -388.26%
May 31, 2024 -367.65%
Feb 29, 2024 -249.79%
Nov 30, 2023 -276.77%
Aug 31, 2023 -200.26%
May 31, 2023 -79.14%
Feb 28, 2023 -321.11%
Nov 30, 2022 -688.74%
Aug 31, 2022 -423.58%
May 31, 2022 -397.14%
Feb 28, 2022 -442.09%
Nov 30, 2021 -509.17%
Aug 31, 2021 -282.46%
API Access

Nurix Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NRIX&period=max&api_key=YOUR_API_KEY